Edwards Lifesciences EW United States — Selling, general, and administrative expenses

Other segment segments

Similar metrics at other companies

VSTSUnited States — Selling, general and administrative expenses

$75.68M-29.9%

PPCU.S. — Selling, general and administrative expense

$109.65M+59.3%

GMEUnited States — Selling, general and administrative expenses

$137.7M-14.1%

MURUnited States — Selling and general expenses

$5.5M+175%

GPIU.S. — Selling, General and Administrative Expense

$418.2M-6.5%

EMEUNITED STATES — Selling, general and administrative expenses

$414.6M+20.3%

Questions, answered.

What is Edwards Lifesciences's united states — selling, general, and administrative expenses?

Edwards Lifesciences (EW) reported united states — selling, general, and administrative expenses of $154.1M in Q1 2026.

How has Edwards Lifesciences's united states — selling, general, and administrative expenses changed year-over-year?

Edwards Lifesciences's united states — selling, general, and administrative expenses increased by 15.7% year-over-year, from $133.2M to $154.1M.

What is the long-term trend for Edwards Lifesciences's united states — selling, general, and administrative expenses?

Over 3 years (2022 to 2025), Edwards Lifesciences's united states — selling, general, and administrative expenses has grown at a 19.1% compound annual growth rate (CAGR), from $340.7M to $575.3M.

What does united states — selling, general, and administrative expenses mean?

This metric encompasses the operating expenses incurred to support sales, marketing, and administrative functions specifically for the United States segment. It reflects the investment in the domestic sales force, clinical education, and regulatory compliance activities necessary to support structural heart product adoption. High levels of these expenses are often required to maintain leadership in specialized medical markets.